TIDMFDBK
Feedback PLC
10 June 2021
Reach announcement
Feedback plc
Bleepa now available on Apple App Store and Google Play
-- Available for download under 'Bleepa' app name
-- App available for all devices including Apple technologies and android devices
-- An essential app for remote, secure communications between
clinicians and teams at the touch of a button
London, 10 June 2021: Feedback plc (AIM: FDBK, "Feedback" or the
"Company"), the specialist medical imaging technology company,
today announces that Bleepa, Feedback's flagship medical imaging
communications platform, has completed a comprehensive evaluation
and is now available for clinicians to download on all devices
through the Apple App Store and Google Play. For hospitals with a
Bleepa contract, clinical users will now be able to simply download
the app and easily access Bleepa through a registered login
process. Access through the Apple App Store and Google Play will
make it easier to roll out Bleepa at customer sites as clinicians
will now be able to download the app directly to their own
devices.
Bleepa is an essential tool for remote, secure communications
between clinicians and teams - an easy-to-use, digital medical
imaging communications platform that enables clinicians to safely
view and discuss imaging and patient cases at the touch of a
button.
-- Bleepa is a CE marked medical device and is the only
regulated platform on the NHSx Clinical Communications Framework
that enables users to share images such as X-ray, CT, MRI or
ultrasound at a standard approved for clinical use.
-- Equipping frontline teams with the ability to see patient
imaging, alongside instant-messaging-based case discussion and
video calls can support them to make more informed decisions
faster, enabling better, safer patient care.
-- Offers latest features including the Photocapture module
which enables clinicians to acquire clinical images of patients,
such as in-field medical photographs of skin lesions or wounds; and
Document Capture to encapsulate additional patient information, ECG
and blood test results within the patient record from which to
share discuss with colleagues.
-- With medical imaging forming the basis of almost all clinical
decision-making processes, flexible access on the go has never been
more essential for a rapidly evolving workforce.
-- Bleepa can facilitate clinical referrals and treatment
decisions within a hospital, between hospitals and pan-regionally
offering truly networked care.
-- As Bleepa can be accessed from any internet-connected device,
it is possible to maintain control of patient cases even when
working remotely. It is easy to create a secure network with all
the information and functionality needed for clinicians to manage
workloads more effectively.
-- From the moment patients are registered, Bleepa can enable
smoother and swifter transfer from one medical team to another,
from referral to decision, treatment and exit.
Dr Tom Oakley, CEO of Feedback, commented:
"We are passionate about improving the lives of those on our
medical frontline, particularly in these COVID-19 times. Bleepa is
revolutionising the way in which clinicians communicate by enabling
clinicians to maintain control even when working remotely, smooth
the patient experience and create a more effective and cohesive
working environment. Bleepa is most effective when used on an
individual's mobile device and our successful approval for both the
Apple App Store and Google Play is a key step in accelerating user
rollout at customer sites. Let's put quality images back where they
belong - in the hands of the frontline - not tomorrow, but right
now, today."
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Feedback media:
Nick Mayhew, Chief Marketing Lead +44 (0) 7736 065353
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Vivek Bhardwaj +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint
Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited
(Joint Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS")-based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute non-regulatory news releases into
the public domain. Information required to be notified under the
AIM Rules for Companies, Market Abuse Regulation or other
regulation would be disseminated as an RNS regulatory announcement
and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUKVSRABUNRAR
(END) Dow Jones Newswires
June 10, 2021 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Apr 2023 to Apr 2024
